These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 25337656)
21. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes. Moffett RC; Patterson S; Irwin N; Flatt PR Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010 [TBL] [Abstract][Full Text] [Related]
22. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle. Arnés L; González N; Tornero-Esteban P; Sancho V; Acitores A; Valverde I; Delgado E; Villanueva-Peñacarrillo ML Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785 [TBL] [Abstract][Full Text] [Related]
24. SAD-A potentiates glucose-stimulated insulin secretion as a mediator of glucagon-like peptide 1 response in pancreatic β cells. Nie J; Lilley BN; Pan YA; Faruque O; Liu X; Zhang W; Sanes JR; Han X; Shi Y Mol Cell Biol; 2013 Jul; 33(13):2527-34. PubMed ID: 23629625 [TBL] [Abstract][Full Text] [Related]
25. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Wang Q; Brubaker PL Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459 [TBL] [Abstract][Full Text] [Related]
26. Evaluating insulin secretagogues in a humanized mouse model with functional human islets. Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177 [TBL] [Abstract][Full Text] [Related]
27. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide. Hashiguchi S; Yada T; Arima T J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358 [TBL] [Abstract][Full Text] [Related]
28. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus. Hare KJ Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021 [TBL] [Abstract][Full Text] [Related]
29. Delayed-rectifier (KV2.1) regulation of pancreatic beta-cell calcium responses to glucose: inhibitor specificity and modeling. Tamarina NA; Kuznetsov A; Fridlyand LE; Philipson LH Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E578-85. PubMed ID: 16014354 [TBL] [Abstract][Full Text] [Related]
30. Swim training restores glucagon-like peptide-1 insulinotropic action in pancreatic islets from monosodium glutamate-obese rats. Svidnicki PV; de Carvalho Leite N; Venturelli AC; Camargo RL; Vicari MR; de Almeida MC; Artoni RF; Nogaroto V; Grassiolli S Acta Physiol (Oxf); 2013 Sep; 209(1):34-44. PubMed ID: 23746147 [TBL] [Abstract][Full Text] [Related]
31. Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition. Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Tanaka I Metabolism; 2003 Jan; 52(1):81-6. PubMed ID: 12524666 [TBL] [Abstract][Full Text] [Related]
32. SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways. Zhou TT; Quan LL; Chen LP; Du T; Sun KX; Zhang JC; Yu L; Li Y; Wan P; Chen LL; Jiang BH; Hu LH; Chen J; Shen X Cell Death Dis; 2016 May; 7(5):e2216. PubMed ID: 27148689 [TBL] [Abstract][Full Text] [Related]
35. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice. Liu L; Wang F; Lu H; Ren X; Zou J Islets; 2014; 6(4):e962386. PubMed ID: 25437377 [TBL] [Abstract][Full Text] [Related]
36. Defective trafficking of Kv2.1 channels in MPTP-induced nigrostriatal degeneration. Chao RY; Cheng CH; Wu SN; Chen PC J Neurochem; 2018 Feb; 144(4):483-497. PubMed ID: 29265365 [TBL] [Abstract][Full Text] [Related]
37. Role of phosphatidylinositol 3-kinasegamma in the beta-cell: interactions with glucagon-like peptide-1. Li LX; MacDonald PE; Ahn DS; Oudit GY; Backx PH; Brubaker PL Endocrinology; 2006 Jul; 147(7):3318-25. PubMed ID: 16574789 [TBL] [Abstract][Full Text] [Related]
38. Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models. Lehtonen J; Schäffer L; Rasch MG; Hecksher-Sørensen J; Ahnfelt-Rønne J Islets; 2015; 7(6):e1137415. PubMed ID: 26963143 [TBL] [Abstract][Full Text] [Related]
39. The voltage-dependent potassium channel subunit Kv2.1 regulates insulin secretion from rodent and human islets independently of its electrical function. Dai XQ; Manning Fox JE; Chikvashvili D; Casimir M; Plummer G; Hajmrle C; Spigelman AF; Kin T; Singer-Lahat D; Kang Y; Shapiro AM; Gaisano HY; Lotan I; Macdonald PE Diabetologia; 2012 Jun; 55(6):1709-20. PubMed ID: 22411134 [TBL] [Abstract][Full Text] [Related]
40. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]